Literature DB >> 21118411

Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease.

K Turkmen1, F Tufan, N Alpay, E Kasıkcioglu, H Oflaz, S A Ecder, T Ecder.   

Abstract

BACKGROUND: Cardiovascular problems are a major cause of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). AIM: The aim of this study was to investigate coronary flow velocity reserve (CFVR) as a marker of endothelial dysfunction, carotid intima media thickness (CIMT) as a marker of subclinical organ damage and insulin resistance (IR) as a cardiovascular risk factor in patients with ADPKD.
METHODS: Twenty-two normotensive ADPKD patients with well-preserved renal function and 19 healthy subjects were included in the study. Creatinine clearances were calculated by the Cockcroft-Gault formula. The homeostasis model of IR (HOMA-IR) was used to measure IR. CIMT was measured by high-resolution vascular ultrasound. CFVR was calculated as the ratio of hyperaemic to baseline diastolic peak velocities by echocardiography.
RESULTS: There was no significant difference between the two groups regarding age, gender, body mass index, systolic and diastolic blood pressures, cholesterol and triglyceride levels. However, CIMT and HOMA-IR were significantly increased and CFVR was significantly decreased in patients with ADPKD compared with healthy subjects.
CONCLUSIONS: The findings of decreased CFVR, increased CIMT and increased IR suggest that cardiovascular risk is elevated even in the early stages of ADPKD.
© 2010 The Authors. Internal Medicine Journal © 2010 Royal Australasian College of Physicians.

Entities:  

Mesh:

Year:  2012        PMID: 21118411     DOI: 10.1111/j.1445-5994.2010.02404.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  5 in total

1.  The relation of anthropometric measurements and insulin resistance in patients with polycystic kidney disease.

Authors:  Bennur Esen; Emel Sağlam Gokmen; Mahmut Kaya; Burak Ozkan; Ahmet Engin Atay
Journal:  J Transl Int Med       Date:  2016-09-23

2.  Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.

Authors:  Cuma Bulent Gul; Abdulmecit Yildiz; Alparslan Ersoy; Serdar Kahvecioglu; Burak Asiltas; Fatih Yildirim; Selime Ermurat; Saim Sag; Aysegul Oruc; Sumeyye Gullulu; Mustafa Gullulu
Journal:  Int Urol Nephrol       Date:  2015-06-06       Impact factor: 2.370

3.  The polymorphism of the ACE gene affects left ventricular hypertrophy and causes disturbances in left ventricular systolic/diastolic function in patients with autosomal dominant polycystic kidney disease.

Authors:  Maria Wanic-Kossowska; Bartlomiej Posnik; Mikolaj Kobelski; Elzbieta Pawliczak; Krzysztof Pawlaczyk; Krzysztof Hoppe; Krzysztof Schwermer; Dorota Sikorska
Journal:  ScientificWorldJournal       Date:  2014-01-02

4.  Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.

Authors:  K Turkmen; F Tufan; E Selçuk; T Akpınar; H Oflaz; T Ecder
Journal:  Indian J Nephrol       Date:  2013-01

5.  New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol.

Authors:  Bo Yang; Sixiu Chen; Guang Yang; Changlin Mei; Albert Ong; Zhiguo Mao
Journal:  BMJ Open       Date:  2015-11-05       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.